GET THE APP

..

Metabolomics:Open Access

ISSN: 2153-0769

Open Access

Citations Report

Metabolomics:Open Access : Citations & Metrics Report

Articles published in Metabolomics:Open Access have been cited by esteemed scholars and scientists all around the world.

Metabolomics:Open Access has got h-index 14, which means every article in Metabolomics:Open Access has got 14 average citations.

Following are the list of articles that have cited the articles published in Metabolomics:Open Access.

  2024 2023 2022 2021 2020 2019 2018

Total published articles

20 15 20 30 24 7 9

Research, Review articles and Editorials

0 0 0 1 2 0 5

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 15 20 29 22 7 4

Conference proceedings

0 0 8 2 2 45 48

Citations received as per Google Scholar, other indexing platforms and portals

959 691 102 110 105 105 96
Journal total citations count 895
Journal impact factor 1.8
Journal 5 years impact factor 3.73
Journal cite score 2.25
Journal h-index 14
Journal h-index since 2019 9
Important citations

Berezin A (2016) Is the neutrophil extracellular trap-driven microvascular inflammation essential for diabetes vasculopathy?. Biomedical Research and Therapy 3: 1-7.

van Ravenzwaay B, Sperber S, Lemke O, Fabian E, Faulhammer F, et al. (2016) Metabolomics as read-across tool: A case study with phenoxy herbicides. Regulatory Toxicology and Pharmacology 81: 288-304.

Seliya B. Research and Reviews: Journal of Zoological Science Pp: s1-s6.

Chekhun VF, Lozovska YV, Naleskina LA, Borikun TV, Burlaka AP, et al. (2016) Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics. Experimental oncology 38: 283.

Cacabelos R (2016) Epigenetics of Brain Disorders: The Paradigm of Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 6: 2161-0460.

Cacabelos R, Torrellas C, Teijido O, Carril JC (2016) Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics 17: 1041-1074.

Ma X, Guo X, Song Y, Qiao L, Wang W, et al. (2016) An Integrated Strategy for Global Qualitative and Quantitative Profiling of Traditional Chinese Medicine Formulas: Baoyuan Decoction as a Case. Scientific Reports.

Yuk J, Patel DN, Isaac G, Smith K, Wrona M, et al. (2016) Chemical Profiling of Ginseng Species and Ginseng Herbal Products Using UPLC/QTOF-MS. Journal of the Brazilian Chemical Society 27: 1476-1483.

Qiu S, Yang WZ, Yao CL, Qiu ZD, Shi XJ, et al. (2016) Nontargeted metabolomic analysis and “commercial-homophyletic” comparison-induced biomarkers verification for the systematic chemical differentiation of five different parts of Panax ginseng. Journal of Chromatography A 1453: 78-87.

Ponting DJ, Murray E, Long A (2017)Quantifying confidence in the reporting of metabolic biotransformations. Drug Discovery Today

Kao D, Ismond KP, Tso V, Millan B, Hotte N, et al. (2016) Urine-based metabolomic analysis of patients with Clostridium difficile infection: a pilot study. Metabolomics 12: 135.

FitzGerald KE, Konduri PC, Vidal C, Yoo H, Zhang L (2017) The Bioenergetic Role of Mitochondria in Lung Cancer. InA Global Scientific Vision-Prevention, Diagnosis, and Treatment of Lung Cancer 2017. InTech.

Alam MM, Lal S, FitzGerald KE, Zhang L (2016) A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors. Clinical and translational medicine 5: 3.

Dey P, Dutta S, Chowdhury A, Das AP, Chaudhuri TK (2017) Variation in Phytochemical Composition Reveals Distinct Divergence of Aloe vera (L.) Burm. f. From Other Aloe Species: Rationale Behind Selective Preference of Aloe vera in Nutritional and Therapeutic Use. Journal of Evidence-Based Complementary & Alternative Medicine :2156587217698292.

Cacabelos R (2016) Epigenetics of Brain Disorders: The Paradigm of Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 6: 2161-0460.

Cacabelos R, Torrellas C, Teijido O, Carril JC (2016) Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics 17: 1041-1074.

Cacabelos R (2015) Impact of genomic medicine on the future of Neuropsychopharmacology. J Neuropsychopharmacol Mental Health 1.

Cacabelos R, Torrellas C (2015) Epigenetics of aging and Alzheimer’s disease: Implications for pharmacogenomics and drug response. International journal of molecular sciences 16: 30483-30543.

Lu DY, Lu TR, Lu Y, Sastry N, Wu HY (2016) Discover Natural Chemical Drugs in Modern Medicines. Metabolomics (Los Angel) 6: 2153-0769.

Lu DY, Lu TR, Xu B, Qi RX, S Yarla N, et al. (2016) Cancer Metastasis, a Clinical Dilemma for Therapeutics. Current Drug Therapy 11: 163-169.

Google Scholar citation report
Citations: 895

Metabolomics:Open Access received 895 citations as per Google Scholar report

Metabolomics:Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward